Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
8%
ALSO IN OZEM
OZEM
22
HOLDINGS
24%
ALSO IN XLV
SECTOR DRIFT (XLV minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.7% | 15.5% | 14.7% |
|
AMGEN INC | 3.6% | 4.1% | 3.6% |
|
PFIZER INC | 2.7% | 4.3% | 2.7% |
|
GILEAD SCIENCES INC | 3.3% | 2.3% | 2.3% |
|
REGENERON PHARMACEUTICALS | 1.4% | 2.8% | 1.4% |
XLV Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 10.1% |
|
ABBVIE INC | 6.9% |
|
MERCK & CO. INC. | 5.3% |
|
UNITEDHEALTH GROUP INC | 4.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 3.4% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
DANAHER CORP | 2.4% |
 |
MEDTRONIC PLC | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -18.1% |
 |
ROCHE HOLDING LTD | -4.5% |
 |
ASCLETIS PHARMA, INC. | -4.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.0% |
 |
HANMI PHARM CO LTD | -4.0% |
|
ZEALAND PHARMA A/S | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.5% |
 |
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |
 |
ASTRAZENECA PLC | -3.2% |
|
INNOVENT BIOLOGICS, INC. | -3.2% |